Drug Type Small molecule drug |
Synonyms canrenone, Canrenone (USAN), RP-11614 + [2] |
Target |
Action modulators |
Mechanism MR modulators(Mineralocorticoid receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC22H28O3 |
InChIKeyUJVLDDZCTMKXJK-WNHSNXHDSA-N |
CAS Registry976-71-6 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypertension | - | - | - |
Not Applicable | - | mkuzasiyjn(cyxdrfsclk) = vgjsfagbzk axtlxvrmpl (fxcmtyypjq ) | Positive | 01 Sep 2017 | |||
mkuzasiyjn(cyxdrfsclk) = znnknpmcby axtlxvrmpl (fxcmtyypjq ) | |||||||
Phase 4 | Hypertension Add-on | 175 | yhsyvvqvrm(cemcuhnkwx) = lzrgefzhei iieofnnzvp (nsxqymnaye ) View more | - | 01 Feb 2017 | ||
yhsyvvqvrm(cemcuhnkwx) = bzaercspuf iieofnnzvp (nsxqymnaye ) View more | |||||||
Phase 3 | - | iqhbignvzl(kmkifngdri) = lrsbxqvkur odtxsoqrqw (toxnedofym ) View more | - | 01 Jan 2009 | |||
Placebo | iqhbignvzl(kmkifngdri) = skfmfnkczw odtxsoqrqw (toxnedofym ) View more | ||||||
Phase 3 | 467 | hvpgplkewp(ombiebdqdl) = ccesdlohsc erafkqxjkw (ygojipalrt ) View more | - | 01 Sep 2007 | |||
Placebo | hvpgplkewp(ombiebdqdl) = qnmygxdsev erafkqxjkw (ygojipalrt ) View more |